FOETAL EXPOSURE TIMING UNSPECIFIED

This adverse event was reported 718 times

These drugs are most commonly taken by patients reporting FOETAL EXPOSURE TIMING UNSPECIFIED:

# Drug Count
0 NATALIZUMAB 55
1 INTERFERON BETA-1A 45
2 FLUOXETINE HYDROCHLORIDE 29
3 DIMETHYL FUMARATE 27
4 AZATHIOPRINE 26
5 NIFEDIPINE 25
6 METHYLDOPA 24
7 ASPIRIN 23
8 ASPIRIN 325 MG 21
9 ASPIRIN 81 MG 21
See all common drugs associated with FOETAL EXPOSURE TIMING UNSPECIFIED

FOETAL EXPOSURE TIMING UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COCAINE HYDROCHLORIDE 4 0.0105
1 METHYLDOPA 24 0.0049
2 ASCIMINIB 4 0.0011
3 LOXAPINE 4 0.0010
4 PHYTONADIONE 7 0.0008
5 PEGINTERFERON BETA-1A 9 0.0007
6 NIFEDIPINE 25 0.0006
7 MYCOPHENILIC ACID 12 0.0006
8 URSOSIOL 11 0.0006
9 URSODIOL 11 0.0005
See all drugs enriched for association with FOETAL EXPOSURE TIMING UNSPECIFIED

FOETAL EXPOSURE TIMING UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 3 0.0014
1 Vitamin K [EPC] 7 0.0008
2 Oxytocic [EPC] 2 0.0007
3 Integrin Receptor Antagonist [EPC] 56 0.0006
4 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 2 0.0006
5 Antimetabolite Immunosuppressant [EPC] 12 0.0006
6 Bile Acid [EPC] 11 0.0005
7 Ergot Derivative [EPC] 2 0.0004
8 Progesterone [EPC] 8 0.0003
9 Interferon beta [EPC] 54 0.0003
See all drug classes enriched for association with FOETAL EXPOSURE TIMING UNSPECIFIED